tyrosyl-isoleucyl-glycyl-seryl-arginine has been researched along with mannose in 1 studies
| Studies (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Trials (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Recent Studies (post-2010) (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Studies (mannose) | Trials (mannose) | Recent Studies (post-2010) (mannose) |
|---|---|---|---|---|---|
| 111 | 0 | 29 | 9,698 | 41 | 2,248 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gordon, CS; Hyacinthe, LM; Jarrett, TW; Vaughan, ED; Whalen, GF | 1 |
1 other study(ies) available for tyrosyl-isoleucyl-glycyl-seryl-arginine and mannose
| Article | Year |
|---|---|
Inhibition of bladder tumor cell implantation in cauterized urothelium, without inhibition of healing, by a fibronectin-related peptide (GRGDS).
Topics: Animals; Antineoplastic Agents; Cautery; Cell Adhesion; Epithelium; Extracellular Matrix; Female; Heparin; Mannose; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Oligopeptides; Urinary Bladder; Urinary Bladder Neoplasms; Wound Healing | 1995 |